Avadel Pharmaceuticals (AVDL) Total Debt: 2009-2021
Historic Total Debt for Avadel Pharmaceuticals (AVDL) over the last 13 years, with Dec 2021 value amounting to $142.4 million.
- Avadel Pharmaceuticals' Total Debt fell 4.12% to $136.2 million in Q3 2022 from the same period last year, while for Sep 2022 it was $136.2 million, marking a year-over-year decrease of 4.12%. This contributed to the annual value of $142.4 million for FY2021, which is 11.07% up from last year.
- Per Avadel Pharmaceuticals' latest filing, its Total Debt stood at $142.4 million for FY2021, which was up 11.07% from $128.2 million recorded in FY2020.
- In the past 5 years, Avadel Pharmaceuticals' Total Debt registered a high of $142.4 million during FY2021, and its lowest value of $98.9 million during FY2017.
- Its 3-year average for Total Debt is $132.6 million, with a median of $128.2 million in 2020.
- Its Total Debt has fluctuated over the past 5 years, first decreased by 25.68% in 2017, then rose by 26.53% in 2018.
- Avadel Pharmaceuticals' Total Debt (Yearly) stood at $98.9 million in 2017, then climbed by 26.53% to $125.2 million in 2018, then increased by 1.65% to $127.2 million in 2019, then climbed by 0.76% to $128.2 million in 2020, then rose by 11.07% to $142.4 million in 2021.